• EMD638683: SGK1 Inhibitor Workflows

  2026-08-15

  EMD638683 enables mechanism-focused SGK1 inhibition in endothelial stiffness, sodium-sensitivity, cancer, and cell-signaling studies. This guide connects phospho-NDRG1 assays with actin remodeling and phenotypic readouts while emphasizing selectivity controls, formulation, and troubleshooting.

• PBA-Modified PAD4 Inhibitors Target Tumor NETs

  2026-08-14

  The reference study developed phenylboronic acid-modified PAD4 inhibitors to improve tumor-associated uptake while suppressing the PAD4–H3cit–NET pathway. Its findings connect tumor-selective delivery with reduced breast cancer growth, metastasis, and immune-microenvironment changes in preclinical models.

• Carbapenemase Transmission in CREC Across Guangdong

  2026-08-14

  Chen et al. characterized carbapenemase-encoding genes, their plasmid or chromosomal locations, transferability, mobile genetic elements, and clonal relationships in 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals. The predominance and high conjugative transfer rate of plasmid-associated blaNDM-1 highlight the importance of combining molecular surveillance, susceptibility testing, and infection-control investigations in antibiotic resistance research.

• AAPH: From Radical Chemistry to Translational Models

  2026-08-13

  A mechanistic and strategic guide to using AAPH (2,2'-Azobis(2-methylpropionamidine) dihydrochloride) for reproducible oxidative stress modeling, antioxidant evaluation, membrane injury studies, and cross-domain translational research.

• Recombinant Annexin V: A Faster Purification Workflow

  2026-08-13

  Burger and colleagues reported a short purification strategy for recombinant annexin V that combines mild bacterial-cell opening, reversible calcium-dependent liposome binding, and final ion-exchange chromatography. The approach produced protein suitable for crystallography, electron microscopy, spectroscopy, and single-channel measurements while addressing contamination introduced by harsher cell-disruption methods.

• Eldecalcitol, Endothelial Ferroptosis, and T2DOP

  2026-08-12

  A 2025 study links endothelial ferroptosis to impaired osteogenesis–angiogenesis coupling in type 2 diabetic osteoporosis and identifies the SOCE/O-GlcNAcylation axis as a mechanism regulated by eldecalcitol. Its integrated cell and mouse experiments suggest that protecting endothelial function may help preserve bone formation under diabetic metabolic stress.

• Ceftazidime: A Phenotype-to-Genotype Bridge

  2026-08-12

  Ceftazidime is a third-generation cephalosporin that connects susceptibility phenotypes with resistance-gene and plasmid-transmission research. This article explains how to use its activity against Gram-negative organisms, especially Pseudomonas aeruginosa, without overinterpreting clinical isolate data.

• γH2AX DNA Damage Detection Kit: From Signal to Decision

  2026-08-11

  The γH2AX DNA Damage Detection Kit provides a spatial readout of DNA double-strand break signaling. This guide explains how to interpret γ-H2AX foci in radiosensitizer, apoptosis, genotoxicity, and DNA repair studies using evidence from recent FLASH-RT research.

• Azilsartan Medoxomil Monopotassium in AT1 Studies

  2026-08-11

  Azilsartan medoxomil monopotassium (TAK 491) provides a sustained, selective AT1-receptor blockade framework for hypertension and cardiovascular research. This article connects receptor pharmacology with the ARAMIS angiotensin II conversion study to improve assay design and translational interpretation.

• Nigericin Sodium Salt: Practical Protocol Guide

  2026-08-10

  Nigericin sodium salt is a potassium ionophore for controlled studies of K+/H+ exchange, ion transport across biological membranes, and cytoplasmic pH changes. This guide covers practical preparation and assay controls, while defining limits for platelet, lead-transport, and cell-based applications when no directly matched paper evidence is available.

• Carbenoxolone disodium: Practical QC Guide

  2026-08-09

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled cell- and tissue-based studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. This guide covers preparation, quality control, and interpretation limits; it should not be treated as an in vivo efficacy protocol or a selective off-target-free intervention.

• Guanabenz Acetate in Stress-Response Assays

  2026-08-08

  Guanabenz Acetate provides a receptor-centered way to perturb α2-adrenergic signaling while monitoring stress-granule and innate-immune phenotypes. This practical workflow connects subtype-aware pharmacology with the GADD34–IRF3 mechanism described in SARS-CoV-2 nucleocapsid research, without treating the compound as a validated antiviral rescue agent.

• IR-820 for In Vivo Imaging: Workflow and Optimization

  2026-08-07

  IR-820 (New Indocyanine Green) supports quantitative near-infrared fluorescence imaging across vascular mapping, tumor localization, and diseased tissue quantification. This practical guide connects reproducible imaging workflows with lessons from a glutathione-responsive indocyanine green nanoplatform study while clearly separating validated evidence from assay-development recommendations.

• Fumagillin: Advancing Methionine Aminopeptidase-2 Inhibitor

  2026-08-07

  Fumagillin stands at the intersection of cancer and aquaculture research as a potent methionine aminopeptidase-2 inhibitor, enabling precise endothelial cell proliferation inhibition and anti-parasitic workflows. This article delivers evidence-backed protocols, cross-domain troubleshooting, and actionable insights to empower researchers leveraging Fumagillin’s unique properties.

• Ertapenem Sodium Salt: Strategic Leverage in Resistance Rese

  2026-08-06

  This article examines the mechanistic and translational value of Ertapenem (sodium salt) in unraveling multidrug resistance among Gram-positive and Gram-negative bacteria, with a focus on carbapenem-resistant Enterobacter cloacae (CREC). Leveraging recent epidemiological insights from Guangdong and referencing APExBIO’s high-purity Ertapenem sodium salt, the discussion provides actionable strategies and protocol guidance for translational researchers, while highlighting unique challenges in clinical surveillance and resistance modeling.

16468 records 1/1098 page Next 12345 下5页 Last page